Related references
Note: Only part of the references are listed.Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
Toyoaki Hida et al.
LANCET (2017)
CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1
Tongzheng Liu et al.
NATURE COMMUNICATIONS (2017)
CCR4 is a determinant of melanoma brain metastasis
Anat Klein et al.
ONCOTARGET (2017)
The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer
Ami N. Shah et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
The role of exosomes in tumor progression and metastasis
Wiktoria M. Suchorska et al.
ONCOLOGY REPORTS (2016)
Targeting CDK4/6 in patients with cancer
Erika Hamilton et al.
CANCER TREATMENT REVIEWS (2016)
Influence of silver and titanium dioxide nanoparticles on in vitro blood-brain barrier permeability
I-Chieh Chen et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2016)
Exosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression
Che-Ming Liu et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases
Amparo Wolf et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)
Anna Sophie Berghoff et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Alice T. Shaw et al.
LANCET ONCOLOGY (2016)
PALBOCICLIB: CDK4/6 INHIBITION IN THE TREATMENT OF ER-POSITIVE BREAST CANCER
J. Owsley et al.
DRUGS OF TODAY (2016)
ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier
Aurore Drolez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Targeted therapies for ER+/HER2-metastatic breast cancer
Mutsuko Yamamoto-Ibusuki et al.
BMC MEDICINE (2015)
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models
Helen Y. Zou et al.
CANCER CELL (2015)
Roles of the Cyclooxygenase 2 Matrix Metalloproteinase 1 Pathway in Brain Metastasis of Breast Cancer
Kerui Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Astrocytes facilitate melanoma brain metastasis via secretion of IL-23
Anat Klein et al.
JOURNAL OF PATHOLOGY (2015)
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers
Deepa Rangachari et al.
LUNG CANCER (2015)
Cerebrospinal fluid concentrations of vemurafenib in patients treated for brain metastatic BRAF-V600 mutated melanoma
Lilia Sakji-Dupre et al.
MELANOMA RESEARCH (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer
David M. Jackman et al.
ONCOTARGET (2015)
Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
Ge Qin et al.
ONCOTARGET (2015)
Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance
Tatsushi Kodama et al.
CANCER LETTERS (2014)
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
Manuel Valiente et al.
CELL (2014)
Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations
Amanda D. Bucheit et al.
CLINICAL CANCER RESEARCH (2014)
In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways
Inderjit Daphu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications
Donna H. Murrell et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Dong-Yeop Shin et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid
Edwin Lok et al.
MELANOMA RESEARCH (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases
Ina Hohensee et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
EGF Receptor Activates MET through MAPK to Enhance Non-Small Cell Lung Carcinoma Invasion and Brain Metastasis
Jerrica L. Breindel et al.
CANCER RESEARCH (2013)
CNS Metastases in Breast Cancer: Old Challenge, New Frontiers
Nancy U. Lin et al.
CLINICAL CANCER RESEARCH (2013)
ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer
Justin F. Gainor et al.
CLINICAL CANCER RESEARCH (2013)
Resistance to BRAF-targeted therapy in melanoma
Ryan J. Sullivan et al.
EUROPEAN JOURNAL OF CANCER (2013)
Role of connexins in metastatic breast cancer and melanoma brain colonization
Konstantin Stoletov et al.
JOURNAL OF CELL SCIENCE (2013)
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study
Takashi Seto et al.
LANCET ONCOLOGY (2013)
Phylogenetic analysis reveals the evolution and diversification of cyclins in eukaryotes
Zhaowu Ma et al.
MOLECULAR PHYLOGENETICS AND EVOLUTION (2013)
Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors
Jong-Mu Sun et al.
LUNG CANCER (2013)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Distinct features of distant metastasis and lymph node stage in lung adenocarcinoma patients with epidermal growth factor receptor gene mutations
Yasunori Enomoto et al.
RESPIRATORY INVESTIGATION (2013)
NRAS mutation status is an independent prognostic factor in metastatic melanoma
John A. Jakob et al.
CANCER (2012)
Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer
Robert C. Doebele et al.
CANCER (2012)
Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP
Nienke A. de Vries et al.
INVESTIGATIONAL NEW DRUGS (2012)
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival Clinical article
Jonathan P. S. Knisely et al.
JOURNAL OF NEUROSURGERY (2012)
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Hector Peinado et al.
NATURE MEDICINE (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An Artificial miRNA against HPSE Suppresses Melanoma Invasion Properties, Correlating with a Down-Regulation of Chemokines and MAPK Phosphorylation
Xiaoyan Liu et al.
PLOS ONE (2012)
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
David P. Kodack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Prognostic Factors for Survival in Melanoma Patients With Brain Metastases
Michael A. Davies et al.
CANCER (2011)
A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
Takaaki Sasaki et al.
CANCER RESEARCH (2011)
Pazopanib Reveals a Role for Tumor Cell B-Raf in the Prevention of HER2(+) Breast Cancer Brain Metastasis
Brunilde Gril et al.
CLINICAL CANCER RESEARCH (2011)
Epidemiology of Metastatic Brain Tumors
Benjamin D. Fox et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation
Oscar Arrieta et al.
RADIATION ONCOLOGY (2011)
Microenvironment Determinants of Brain Metastasis
Chenyu Zhang et al.
CELL AND BIOSCIENCE (2011)
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases
Barbara Adamo et al.
BREAST CANCER RESEARCH (2011)
Astrocytes: biology and pathology
Michael V. Sofroniew et al.
ACTA NEUROPATHOLOGICA (2010)
Chemokine-chemokine receptor axes in melanoma brain metastasis
Sivan Izraely et al.
IMMUNOLOGY LETTERS (2010)
High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer
Jennifer L. Clarke et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Real-time imaging reveals the single steps of brain metastasis formation
Yvonne Kienast et al.
NATURE MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab
Mariantonietta Colozza et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
Michael A. Davies et al.
CLINICAL CANCER RESEARCH (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
Anna L. Bartels et al.
NEUROBIOLOGY OF AGING (2009)
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Hui-Zi Chen et al.
NATURE REVIEWS CANCER (2009)
Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies
Itaru Matsumura et al.
CANCER SCIENCE (2008)
The blood-central nervous system barriers actively control immune cell entry into the central nervous system
Britta Engelhardt
CURRENT PHARMACEUTICAL DESIGN (2008)
Mutational analysis of the BRAF gene in human tumor cells
Masatsugu Ueda et al.
HUMAN CELL (2008)
Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain
Brunilde Gril et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: A treatment challenge
Hans-Joachim Stemmler et al.
ONCOLOGIST (2008)
P-glycoprotein and breast cancer resistance protein: Two dominant transporters working together in limiting the brain penetration of topotecan
Nienke A. de Vries et al.
CLINICAL CANCER RESEARCH (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Myeloid cell trafficking and tumor angiogenesis
Michael C. Schmid et al.
CANCER LETTERS (2007)
Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer - Clinical implications for the subsequent management of the brain
Allen M. Chen et al.
CANCER (2007)
Reactivation of Snail genes in renal fibrosis and carcinomas -: A process of reversed embryogenesis?
Agnes Boutet et al.
CELL CYCLE (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain
Robert M. Prins et al.
JOURNAL OF IMMUNOLOGY (2006)
Distribution of sunitinib and its active metabolite in brain and spinal cord tissue following oral or intravenous administration in rodents and monkeys
S. Patyna et al.
EJC SUPPLEMENTS (2006)
Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression
Chang Xia et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Activation of Stat3 in human melanoma promotes brain metastasis
TX Xie et al.
CANCER RESEARCH (2006)
Heparanase brain: Mechanisms of melanoma metastasis to the development and use of a brain slice model
BP Murry et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Vascular damage after fractionated whole-brain irradiation in rats
WR Brown et al.
RADIATION RESEARCH (2005)
Treatment options for brain metastases from melanoma
Robert R. McWilliams et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2005)
Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by Erlotinib (Tarceva)
P Chinnaiyan et al.
CANCER RESEARCH (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability
ML Criscuoli et al.
BLOOD (2005)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
NPM/ALK downregulates p27Kip1 in a PI-3K-dependent manner
A Slupianek et al.
EXPERIMENTAL HEMATOLOGY (2004)
Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice
LS Kim et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
A Zamo et al.
ONCOGENE (2002)
Doxorubicin-peptide conjugates overcome multidrug resistance
M Mazel et al.
ANTI-CANCER DRUGS (2001)
Share Paper
